AZACITIDINE
Informations Générales
| Élément | Valeur |
|---|---|
| DrugBank ID | DB00928 |
| Niveau de Preuve | L5 (Prédiction Computationnelle) |
| Nombre d'Indications Prédites | 17 |
Indications Prédites (TxGNN)
Les suivantes sont des indications potentielles nouvelles prédites par le modèle TxGNN. Des scores plus élevés indiquent une pertinence prédite plus élevée.
| # | Indication | Source |
|---|---|---|
| 1 | unclassified acute myeloid leukemia | TxGNN Knowledge Graph |
| 2 | acute myeloid leukemia with minimal differentiation | TxGNN Knowledge Graph |
| 3 | acute myeloid leukemia with t(8;21)(q22;q22) translocation | TxGNN Knowledge Graph |
| 4 | acute myeloid leukemia with NPM1 somatic mutations | TxGNN Knowledge Graph |
| 5 | acute myeloid leukemia with t(9;11)(p22;q23) | TxGNN Knowledge Graph |
| 6 | inherited acute myeloid leukemia | TxGNN Knowledge Graph |
| 7 | acute myeloblastic leukemia without maturation | TxGNN Knowledge Graph |
| 8 | acute myeloid leukemia with t(6;9)(p23;q34) | TxGNN Knowledge Graph |
| 9 | myeloid leukemia | TxGNN Knowledge Graph |
| 10 | myelomonocytic leukemia | TxGNN Knowledge Graph |
| 11 | acute myeloid leukemia with t(8;16)(p11;p13) translocation | TxGNN Knowledge Graph |
| 12 | acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | TxGNN Knowledge Graph |
| 13 | therapy related acute myeloid leukemia and myelodysplastic syndrome | TxGNN Knowledge Graph |
| 14 | acute myeloblastic leukemia with maturation | TxGNN Knowledge Graph |
| 15 | myelodysplastic syndrome | TxGNN Knowledge Graph |
| 16 | acute myeloid leukemia with CEBPA somatic mutations | TxGNN Knowledge Graph |
| 17 | acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | TxGNN Knowledge Graph |
Avertissement
Ces prédictions sont uniquement à des fins de recherche et ne constituent pas un avis médical. Une validation clinique est requise avant toute application clinique.